Skip to main content

GUGGENHEIM CAPITAL LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1283072 Chicago, IL

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
56,801
+55.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GUGGENHEIM CAPITAL LLC holds $210,403,156 across 75 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 56,801
2025-12-31 36,647
2025-09-30 33,834
2025-06-30 38,453
2025-03-31 35,348
2024-12-31 32,607
2024-09-30 37,929
2024-06-30 33,613
2024-03-31 33,502
2023-12-31 31,570
2023-09-30 41,105
2023-06-30 31,460
2023-03-31 35,992
2022-12-31 48,807
2022-09-30 35,519
2022-06-30 41,678
2022-03-31 43,099
2021-12-31 48,251
2021-09-30 43,644